Clinical Trial Update: Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, preliminary efficacy and pharmacokinetics of the investigational agent 3810 in patients with advanced solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Solid Tumors

Drugs mentioned

• 3810

Snippet

Sponsor: Haihe Biopharma Co., Ltd. | Conditions: Advanced Solid Tumor, Advanced/Metastatic Colorectal Cancer | Phase 1 | Status: UNKNOWN